|
Joint pain, once considered an ailment of aging, is now recognized as one of the most common orthopedic conditions in the human and equine world. OVC researchers Koch and Koenig have been involved in several stem cell studies with funding provided by equine industry partners of Equine Guelph*, Grayson-Jockey Club Research Foundation, NSERC, CIHR and private industry partners.
A new clinical trial at OVC, led by Koenig will explore the efficacy of umbilical cord blood stem cells to treat mild joint pain. This study is currently enrolling horses who have been diagnosed with synovitis or osteoarthritis.
Read on...
*Equine Guelph supports a number of high-quality projects at the University of Guelph, by virtue of funding provided largely by the racing industry (Standardbred, Thoroughbred and Quarter horse organizations): the Horse Improvement Program from the Horsemen’s Benevolent and Protective Association and the E.P. Taylor Foundation, started by veterinarians in the Thoroughbred industry, and now maintained in trust by the University and Equine Guelph.
| 
